1. Home
  2. PENN vs SLNO Comparison

PENN vs SLNO Comparison

Compare PENN & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PENN
  • SLNO
  • Stock Information
  • Founded
  • PENN 1972
  • SLNO 1999
  • Country
  • PENN United States
  • SLNO United States
  • Employees
  • PENN N/A
  • SLNO N/A
  • Industry
  • PENN Hotels/Resorts
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PENN Consumer Discretionary
  • SLNO Health Care
  • Exchange
  • PENN Nasdaq
  • SLNO Nasdaq
  • Market Cap
  • PENN 2.6B
  • SLNO 2.3B
  • IPO Year
  • PENN 1994
  • SLNO 2014
  • Fundamental
  • Price
  • PENN $16.92
  • SLNO $71.99
  • Analyst Decision
  • PENN Buy
  • SLNO Strong Buy
  • Analyst Count
  • PENN 21
  • SLNO 8
  • Target Price
  • PENN $23.38
  • SLNO $92.00
  • AVG Volume (30 Days)
  • PENN 4.0M
  • SLNO 1.8M
  • Earning Date
  • PENN 05-01-2025
  • SLNO 05-08-2025
  • Dividend Yield
  • PENN N/A
  • SLNO N/A
  • EPS Growth
  • PENN N/A
  • SLNO N/A
  • EPS
  • PENN N/A
  • SLNO N/A
  • Revenue
  • PENN $6,578,100,000.00
  • SLNO N/A
  • Revenue This Year
  • PENN $8.65
  • SLNO N/A
  • Revenue Next Year
  • PENN $5.11
  • SLNO N/A
  • P/E Ratio
  • PENN N/A
  • SLNO N/A
  • Revenue Growth
  • PENN 3.38
  • SLNO N/A
  • 52 Week Low
  • PENN $13.50
  • SLNO $36.61
  • 52 Week High
  • PENN $23.08
  • SLNO $73.97
  • Technical
  • Relative Strength Index (RSI)
  • PENN 37.89
  • SLNO 84.44
  • Support Level
  • PENN $17.16
  • SLNO $48.29
  • Resistance Level
  • PENN $17.73
  • SLNO $51.88
  • Average True Range (ATR)
  • PENN 0.65
  • SLNO 3.03
  • MACD
  • PENN 0.07
  • SLNO 2.32
  • Stochastic Oscillator
  • PENN 50.91
  • SLNO 93.61

About PENN PENN Entertainment Inc.

Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 89% of total sales in 2023; 11% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: